name,category,termsDNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),BIOCARTA[30000048$h_caspasePathway:Caspase Cascade in Apoptosis, 30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors , 30000084$h_DNAfragmentPathway:Apoptotic DNA fragmentation and tissue homeostasis, 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000188$h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling, 30000268$h_setPathway:Granzyme A mediated Apoptosis Pathway, 30000297$h_tnfr1Pathway:TNFR1 Signaling Pathway]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),INTERPRO[450003076$IPR003508:Caspase-activated nuclease CIDE-N, 450013753$IPR015311:Apoptosis, DNA fragmentation factor 40 kDa]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),KEGG_PATHWAY[470038843$hsa04210:Apoptosis]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),SMART[760000238$SM00266:CAD]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus, 790001212$polymorphism]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),UP_SEQ_FEATURE[850015551$chain:DNA fragmentation factor subunit beta, 850103367$domain:CIDE-N, 850105852$helix, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
WNK lysine deficient protein kinase 1; hypothetical LOC100132369,INTERPRO[450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
WNK lysine deficient protein kinase 1; hypothetical LOC100132369,OMIM_DISEASE[520003613$Neuropathy, hereditary sensory and autonomic, type II, 520004158$Pseudohypoaldosteronism, type IIC]
WNK lysine deficient protein kinase 1; hypothetical LOC100132369,SP_PIR_KEYWORDS[790000052$alternative promoter usage, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001260$protein kinase inhibitor, 790001388$serine/threonine-protein kinase, 790001547$transferase]
WNK lysine deficient protein kinase 1; hypothetical LOC100132369,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850060062$chain:Serine/threonine-protein kinase WNK1, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 19 open reading frame 71,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 19 open reading frame 71,UP_SEQ_FEATURE[850073534$chain:Uncharacterized protein C19orf71, 850117295$sequence variant]
low density lipoprotein receptor-related protein 5,INTERPRO[450000026$IPR000033:Low-density lipoprotein receptor, YWTD repeat, 450001927$IPR002172:Low density lipoprotein-receptor, class A, cysteine-rich, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450010012$IPR011042:Six-bladed beta-propeller, TolB-like, 450011699$IPR013032:EGF-like region, conserved site, 450015369$IPR017049:Low density lipoprotein receptor-related protein, 5/6, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
low density lipoprotein receptor-related protein 5,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway]
low density lipoprotein receptor-related protein 5,OMIM_DISEASE[520000647$Bone mineral density variability 1, 520000650$Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study, 520001836$Exudative vitreoretinopathy 4, 520002450$Hyperostosis, endosteal, 520003818$Osteopetrosis, AD type I, 520003831$Osteoporosis, 520003837$Osteoporosis-pseudoglioma syndrome, 520003840$Osteosclerosis, 520005010$van Buchem disease, type 2]
low density lipoprotein receptor-related protein 5,PIR_SUPERFAMILY[630027750$PIRSF036314:LDL_recpt-rel_p5/6, 630027751$PIRSF036314:low density lipoprotein receptor-related protein, 5/6 types, 630030929$PIRSF500770:low-density lipoprotein receptor-related protein 5]
low density lipoprotein receptor-related protein 5,SMART[760000117$SM00135:LY, 760000155$SM00181:EGF, 760000166$SM00192:LDLa]
low density lipoprotein receptor-related protein 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000496$Endocytosis, 790000616$glycoprotein, 790000881$lipoprotein, 790000919$membrane, 790001084$osteopetrosis, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001642$wnt signaling pathway]
low density lipoprotein receptor-related protein 5,UP_SEQ_FEATURE[850029132$chain:Low-density lipoprotein receptor-related protein 5, 850102586$compositionally biased region:Pro-rich, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103623$domain:EGF-like 2, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850104665$domain:LDL-receptor class A 1, 850104678$domain:LDL-receptor class A 2, 850104691$domain:LDL-receptor class A 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850116264$repeat:LDL-receptor class B 1, 850116265$repeat:LDL-receptor class B 10, 850116266$repeat:LDL-receptor class B 11, 850116267$repeat:LDL-receptor class B 12, 850116268$repeat:LDL-receptor class B 13, 850116269$repeat:LDL-receptor class B 14, 850116270$repeat:LDL-receptor class B 15, 850116271$repeat:LDL-receptor class B 16, 850116272$repeat:LDL-receptor class B 17, 850116273$repeat:LDL-receptor class B 18, 850116274$repeat:LDL-receptor class B 19, 850116275$repeat:LDL-receptor class B 2, 850116276$repeat:LDL-receptor class B 20, 850116286$repeat:LDL-receptor class B 3, 850116295$repeat:LDL-receptor class B 4, 850116296$repeat:LDL-receptor class B 5, 850116297$repeat:LDL-receptor class B 6, 850116298$repeat:LDL-receptor class B 7, 850116299$repeat:LDL-receptor class B 8, 850116300$repeat:LDL-receptor class B 9, 850117267$repeat:YWTD 1, 850117268$repeat:YWTD 10, 850117269$repeat:YWTD 11, 850117270$repeat:YWTD 2, 850117271$repeat:YWTD 3, 850117272$repeat:YWTD 4, 850117273$repeat:YWTD 5, 850117274$repeat:YWTD 6, 850117275$repeat:YWTD 7, 850117276$repeat:YWTD 8, 850117277$repeat:YWTD 9, 850117294$sequence conflict, 850117295$sequence variant, 850117651$short sequence motif:PPPSP motif, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
microspherule protein 1,INTERPRO[450000219$IPR000253:Forkhead-associated]
microspherule protein 1,SMART[760000212$SM00240:FHA]
microspherule protein 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
microspherule protein 1,UP_SEQ_FEATURE[850031678$chain:Microspherule protein 1, 850102597$compositionally biased region:Ser-rich, 850103775$domain:FHA, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2,INTERPRO[450001470$IPR001660:Sterile alpha motif SAM, 450010372$IPR011510:Sterile alpha motif homology 2]
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2,PIR_SUPERFAMILY[630018477$PIRSF022556:LAR-interacting protein]
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2,SMART[760000399$SM00454:SAM]
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001304$repeat]
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2,UP_SEQ_FEATURE[850028886$chain:Liprin-alpha-2, 850102507$compositionally biased region:Glu-rich, 850102568$compositionally biased region:Poly-Asp, 850105250$domain:SAM 1, 850105251$domain:SAM 2, 850105252$domain:SAM 3, 850106258$modified residue]
signal peptidase complex subunit 2 homolog (S. cerevisiae); signal peptidase complex subunit 2 homolog pseudogene,INTERPRO[450008676$IPR009582:Microsomal signal peptidase 25 kDa subunit]
signal peptidase complex subunit 2 homolog (S. cerevisiae); signal peptidase complex subunit 2 homolog pseudogene,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000743$hydrolase, 790000919$membrane, 790000959$microsome, 790001252$Protease, 790001555$transmembrane]
signal peptidase complex subunit 2 homolog (S. cerevisiae); signal peptidase complex subunit 2 homolog pseudogene,UP_SEQ_FEATURE[850060751$chain:Signal peptidase complex subunit 2, 850106258$modified residue, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
tumor protein p53 regulated apoptosis inducing protein 1,KEGG_PATHWAY[470038836$hsa04115:p53 signaling pathway]
tumor protein p53 regulated apoptosis inducing protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism]
tumor protein p53 regulated apoptosis inducing protein 1,UP_SEQ_FEATURE[850036662$chain:p53-regulated apoptosis-inducing protein 1, 850117295$sequence variant, 850118574$splice variant]
up-regulated during skeletal muscle growth 5 homolog (mouse),INTERPRO[450008245$IPR009125:DAPIT]
up-regulated during skeletal muscle growth 5 homolog (mouse),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790001555$transmembrane]
up-regulated during skeletal muscle growth 5 homolog (mouse),UP_SEQ_FEATURE[850083125$chain:Up-regulated during skeletal muscle growth protein 5, 850106258$modified residue, 850118623$transmembrane region]
